Point72 Asia (Singapore) Pte. Ltd. Lexicon Pharmaceuticals, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $381 Billion
- Q1 2025
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 171,147 shares of LXRX stock, worth $92,419. This represents 0.02% of its overall portfolio holdings.
Number of Shares
171,147Holding current value
$92,419% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding LXRX
# of Institutions
134Shares Held
196MCall Options Held
310KPut Options Held
77.3K-
Artal Group S.A. Luxembourg, N4136MShares$73.5 Million100.0% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$5.34 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.56MShares$5.16 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.21MShares$4.44 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA3.69MShares$1.99 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $102M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...